UI Hospitals and Clinics

Clinical Trial Details

Short Title
PET/CT Imaging for Pelvic Cancers
Official Title

[F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers


[F-18] Fluorothymidine PET imaging will be used to create a radiation therapy treatment plan to avoid active bone marrow in the pelvis. This will be done to evaluate if sparing bone marrow will help maintain blood counts. This would impact chemotherapy administration.

For further information, please visit:


Start Date
October 1, 2012
End Date
October 1, 2022
Gender Preference
Age Group
18 - 99 years
Principal Investigator
Sarah McGuire, MD
Contact Info

Sandy Vollstedt, 319-353-7143

Department or Field of Study

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.